Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Rubinstein

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2006
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activityMohamed Labib Salem, William E Gillanders, Andre N Kadima, et al.
Blood|August 12, 2008
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune responseMark P Rubinstein, Nicholas A Lind, Jared F Purton, et al.
The Journal of Experimental Medicine|August 1, 2007
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2Jae-Ho Cho, Onur Boyman, Hee-Ok Kim, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
A workflow for targeted proteomics assay development using a versatile linear ion trapAriana E Shannon, Rachael N Teodorescu, Nojoon Soon, et al.
Journal of Hematology & Oncology|November 28, 2013
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responsesMark P Rubinstein, Mohamed L Salem, Andrew L Doedens, et al.
Cancer Immunology, Immunotherapy : CII|January 31, 2016
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicKinga Majchrzak, Michelle H Nelson, Stefanie R Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2025
IL-2 complex therapy prolongs fully MHC-mismatched murine cardiac allograft survivalIkbale El-Ayachi, Rachael N Teodorescu, Joseph Azar, et al.
Frontiers in Oncology|December 11, 2023
Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancerZachary Gao, Sung Wook Kang, Derek Erstad, et al.
Cancer Research|April 17, 2008
Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cellsMathieu Epardaud, Kutlu G Elpek, Mark P Rubinstein, et al.
Cancer Medicine|February 9, 2021
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparitiesThomas Curran, Zequn Sun, Brielle Gerry, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2006
Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activityMohamed Labib Salem, William E Gillanders, Andre N Kadima, et al.
Blood|August 12, 2008
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune responseMark P Rubinstein, Nicholas A Lind, Jared F Purton, et al.
The Journal of Experimental Medicine|August 1, 2007
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2Jae-Ho Cho, Onur Boyman, Hee-Ok Kim, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
A workflow for targeted proteomics assay development using a versatile linear ion trapAriana E Shannon, Rachael N Teodorescu, Nojoon Soon, et al.
Journal of Hematology & Oncology|November 28, 2013
G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responsesMark P Rubinstein, Mohamed L Salem, Andrew L Doedens, et al.
Cancer Immunology, Immunotherapy : CII|January 31, 2016
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicKinga Majchrzak, Michelle H Nelson, Stefanie R Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2025
IL-2 complex therapy prolongs fully MHC-mismatched murine cardiac allograft survivalIkbale El-Ayachi, Rachael N Teodorescu, Joseph Azar, et al.
Frontiers in Oncology|December 11, 2023
Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancerZachary Gao, Sung Wook Kang, Derek Erstad, et al.
Cancer Research|April 17, 2008
Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cellsMathieu Epardaud, Kutlu G Elpek, Mark P Rubinstein, et al.
Cancer Medicine|February 9, 2021
Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparitiesThomas Curran, Zequn Sun, Brielle Gerry, et al.
Pageof 8